|
SF3B1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.801400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.741400E-01 |
| Normal-vs-Stage2 |
3.958400E-01 |
| Normal-vs-Stage3 |
5.901600E-01 |
| Normal-vs-Stage4 |
4.721000E-01 |
| Stage1-vs-Stage2 |
6.189200E-01 |
| Stage1-vs-Stage3 |
4.265600E-01 |
| Stage1-vs-Stage4 |
5.079200E-01 |
| Stage2-vs-Stage3 |
2.448000E-01 |
| Stage2-vs-Stage4 |
3.038800E-01 |
| Stage3-vs-Stage4 |
8.523600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.998000E-01 |
| Normal-vs-AfricanAmerican |
5.667000E-01 |
| Normal-vs-Asian |
6.845400E-01 |
| Caucasian-vs-AfricanAmerican |
8.141200E-01 |
| Caucasian-vs-Asian |
6.144000E-01 |
| AfricanAmerican-vs-Asian |
6.481000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.180200E-01 |
| Normal-vs-Female |
2.644500E-02 |
| Male-vs-Female |
2.442200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.931800E-01 |
| Normal-vs-Extreme_Weight |
6.068600E-01 |
| Normal-vs-Obese |
2.783400E-01 |
| Normal-vs-Extreme_Obese |
5.764600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.027000E-01 |
| Normal_Weight-vs-Obese |
4.900400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.916200E-01 |
| Extreme_Weight-vs-Obese |
1.390600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.848400E-01 |
| Obese-vs-Extreme_Obese |
3.435600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.520000E-03 |
| Normal-vs-Age(41-60Yrs) |
5.120200E-02 |
| Normal-vs-Age(61-80Yrs) |
8.934800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.485000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.670000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.325800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.263400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.739900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.589600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.280200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.433600E-02 |
| Normal-VS-Type2 PRCC |
5.170500E-02 |
| Normal-VS-KIRP CIMP |
5.649800E-01 |
| Normal-VS-Unclassified PRCC |
1.727600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.62340000000084E-05 |
| Type1 PRCC-VS-KIRP CIMP |
8.468600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.366200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.048610E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.026010E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.780600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.658400E-01 |
| Normal-vs-N1 |
2.693400E-01 |
| Normal-vs-N2 |
6.951600E-01 |
| N0-vs-N1 |
8.541500E-02 |
| N0-vs-N2 |
9.515200E-01 |
| N1-vs-N2 |
4.891000E-01 |
|
|
